Nitnib 50mg contains Sunitinib Malate, a targeted cancer therapy used to treat certain types of cancers including advanced renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET).
| Composition | Sunitinib |
| Manufacturer | Zydus Cadila |
| Packing | 7 Capsules |
| Prescribed For | Kidney Cancer, Gastrointestinal Stromal Tumors & Pancreatic Neuroendocrine Tumors |
| Expiry | December 2027 |
Sunicine 50mg Capsule contains Sunitinib, a targeted cancer therapy used to treat various cancers, including advanced kidney cancer (Renal Cell Carcinoma), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET).
| Composition | Sunitinib |
| Manufacturer | Arechar Healthcare |
| Packing | 28 Capsules in 1 Bottle |
| Prescribed For | Kidney Cancer and GIST, pNET |
| Expiry | December 2027 |
Sunisam 50 mg Capsules contains Sunitinib, an oral targeted therapy used in the treatment of various cancers, including advanced kidney cancer (Renal Cell Carcinoma), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors (pNET).
| Composition | Sunitinib |
| Manufacturer | Samarth Life Sciences Pvt Ltd |
| Packing | 28 Capsules |
| Prescribed For | Kidney Cancer, GIST and pNET |
| Expiry | December 2027 |
Sunitax 25 mg capsule is a targeted cancer therapy containing Sunitinib Malate, used primarily to treat certain types of advanced cancers such as renal cell carcinoma (kidney cancer) and gastrointestinal stromal tumors (GIST).
| Composition | Sunitinib |
| Manufacturer | Aureate Healthcare Pvt Ltd |
| Packing | 7 Capsules in 1 Strip |
| Prescribed For | Kidney Cancer and Gastrointestinal Stromal Tumors |
| Expiry | December 2027 |
Sunixar 25/50mg Capsule is an oral cancer medication containing Sunitinib Malate, used to treat advanced kidney cancer (renal cell carcinoma), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Manufacturer | Sun Pharmaceutical Industries Ltd |
| Packing | 7 capsules in 1 Strip |
| Prescribed For | Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumors |
| Expiry | December 2027 |
Sutekast 50 mg Capsule is an oral cancer medication containing Sunitinib Malate, used in the treatment of advanced cancers such as renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Manufacturer | Aprazer Healthcare Pvt Ltd |
| Packing | 28 Capsules in 1 Bottle |
| Prescribed For | Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumors |
| Expiry | December 2027 |
Sutib 50mg Capsule contains Sunitinib Malate, a targeted cancer treatment used for managing advanced cancers such as renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Manufacturer | Glenmark Pharmaceuticals Ltd |
| Packing | 28 Capsules |
| Prescribed For | Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumors |
| Expiry | December 2027 |
Sutinat 50mg Capsule is an oral anti-cancer medication that contains Sunitinib Malate, a targeted therapy used to treat certain advanced cancers such as renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Manufacturer | Natco Pharma Ltd |
| Packing | 28 Capsules in 1 Bottle |
| Prescribed For | Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumors |
| Expiry | December 2027 |
Sutykine 50 mg Capsule is an oral targeted therapy that contains Sunitinib Malate, used in the treatment of advanced cancers such as renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Manufacturer | Intas Pharmaceuticals Ltd |
| Packing | 70 Capsules |
| Prescribed For | Anticancer |
| Expiry | December 2027 |
Svitinib 50mg Capsule is an oral anti-cancer medication containing Sunitinib Malate, a targeted therapy used in the treatment of renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Packing | 30 Capsules |
| Prescribed For | Kidney Cancer, GIST and Pancreatic Neuroendocrine Tumors |
| Expiry | December 2027 |
Tunib 50mg Capsule contains Sunitinib Malate, a targeted cancer therapy used to treat advanced renal cell carcinoma (kidney cancer), gastrointestinal stromal tumors (GIST), and certain types of pancreatic neuroendocrine tumors.
| Composition | Sunitinib |
| Manufacturer | Mankind Pharmaceuticals Limited |
| Packing | 28 Capsules in 1 Bottle |
| Prescribed For | Kidney Cancer |
| Expiry | December 2027 |
